These targeted approaches are limited to our understanding of the pathways involved in breast cancer etiology, and have thus mainly identified new breast cancer susceptibility alleles within genes either coding for proteins that interact with BRCA1 or BRCA2 (e.g., PALB2), or other genes involved in DNA repair processes, such as ATM and CHEK2. The gene discussed is CHEK2; the disease is breast carcinoma.